Cargando…

Health State Utility Data in Cystic Fibrosis: A Systematic Review

INTRODUCTION: Cystic fibrosis (CF) is a life-limiting, hereditable condition, with the highest prevalence in Europe. CF treatments have led to improvements in clinical symptoms, disease management and decelerated disease progression. However, little is known about the health state utility (HSU) asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohindru, Bishal, Turner, David, Sach, Tracey, Bilton, Diana, Carr, Siobhan, Archangelidi, Olga, Bhadhuri, Arjun, Whitty, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018933/ https://www.ncbi.nlm.nih.gov/pubmed/31054048 http://dx.doi.org/10.1007/s41669-019-0144-1

Ejemplares similares

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review
por: Stanford, Gemma E., et al.
Publicado: (2022)

The Economic Costs of Type 2 Diabetes: A Global Systematic Review
por: Seuring, Till, et al.
Publicado: (2015)

Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis
por: Newsome, Simon J, et al.
Publicado: (2021)

Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis
por: Altabee, Rana, et al.
Publicado: (2022)

Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden
por: Cameron, Rory A., et al.
Publicado: (2022)

Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review
por: Ciuca, Ioana Mihaiela, et al.
Publicado: (2022)

Hyperglycemia and Death in Cystic Fibrosis–Related Diabetes
por: Adler, Amanda I., et al.
Publicado: (2011)

Diabetes as a Determinant of Mortality in Cystic Fibrosis
por: Chamnan, Parinya, et al.
Publicado: (2010)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK
por: Keogh, Ruth H., et al.
Publicado: (2020)

Caregiver burden in cystic fibrosis: a systematic literature review
por: Daly, Conor, et al.
Publicado: (2022)

Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis
por: Hughes, Dominic A., et al.
Publicado: (2021)

Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
por: Higgins, Mark, et al.
Publicado: (2020)

Effects of Exercise on Nutritional Status in People with Cystic Fibrosis: A Systematic Review
por: Nicolson, William B., et al.
Publicado: (2022)

Effectiveness of Video Games as Physical Treatment in Patients with Cystic Fibrosis: Systematic Review
por: López-Liria, Remedios, et al.
Publicado: (2022)

Normal reference values for aerobic fitness in cystic fibrosis: a scoping review
por: Tomlinson, Owen W, et al.
Publicado: (2022)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data()
por: Keogh, Ruth H., et al.
Publicado: (2018)

Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information
por: Keogh, Ruth H., et al.
Publicado: (2019)

Isolation Systems and its Effectiveness in Oral and Maxillofacial Surgery: A Systematic Review
por: Tiwari, Rahul V. C., et al.
Publicado: (2023)

Optimising inhaled mannitol for cystic fibrosis in an adult population
por: Flume, Patrick A., et al.
Publicado: (2015)

Forced Oscillation Technique for Monitoring the Respiratory Status of Children with Cystic Fibrosis: A Systematic Review
por: Loukou, Ioanna, et al.
Publicado: (2021)

Prevalence of Nontuberculous Mycobacteria in Cystic Fibrosis Clinics, United Kingdom, 2009
por: Seddon, Paul, et al.
Publicado: (2013)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

Genetic Determinants and Epidemiology of Cystic Fibrosis–Related Diabetes: Results from a British cohort of children and adults
por: Adler, Amanda I., et al.
Publicado: (2008)

Effects of Exercise Training on Peripheral Muscle Strength in Children and Adolescents with Cystic Fibrosis: A Meta-Analysis
por: Thorel, Anna, et al.
Publicado: (2022)

A Systematic Review of the Effect of Cystic Fibrosis Treatments on the Nasal Potential Difference Test in Animals and Humans
por: Leenaars, Cathalijn, et al.
Publicado: (2023)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Screening Methods for Diagnosing Cystic Fibrosis-Related Diabetes: A Network Meta-Analysis of Diagnostic Accuracy Studies
por: Izsák, Vera Dóra, et al.
Publicado: (2021)

Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series
por: Kayria, Muttardi, et al.
Publicado: (2017)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

Utilization of the Healthy Eating Index in Cystic Fibrosis
por: Bass, Rosara Milstein, et al.
Publicado: (2022)

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
por: Elborn, JS, et al.
Publicado: (2016)

Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis
por: Stanford, Gemma, et al.
Publicado: (2019)

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
por: Bessonova, Leona, et al.
Publicado: (2018)

Learning to breathe with Tai Chi online - qualitative data from a randomized controlled feasibility study of patients with cystic fibrosis
por: Ronan, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hk6k937kjg70v2d7pkhdsfaibb